Eye drops for dry eye disease: a phase 3 study
Part of Eyes & vision clinical trials.
This study tests an eye drop called lifitegrast for people with dry eye disease. It looks at whether the drops can improve eye comfort, reduce dryness, and help eye surface health. You may be able to join if you have had dry eye symptoms and used artificial tears in the past month.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had dry eye symptoms in both eyes (like dryness, burning, or discomfort) and have used artificial tears in the last 30 days.
- You are willing to stop artificial tears for at least 72 hours before the screening and not use them during the study.
- You do not have other eye diseases (like glaucoma, infections, or recent surgery) that could affect the results.
- You are not pregnant, breastfeeding, or planning to become pregnant, and you agree to use birth control if needed.
- You have not used certain eye medications (like cyclosporine, steroids, or antihistamines) within the past 2 to 6 weeks, depending on the drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.
This trial tests an experimental eye drop (RCI001) to see if it's better than a placebo at relieving dry eye symptoms. It might help if you have moderate to severe dry eye and are looking for a new treatment.
This study tests new artificial tear drops to see if they are safe and effective for people with dry eye disease. If you have dry eyes, these drops might help reduce symptoms and improve eye comfort.
This study tests whether over-the-counter lubricating eye drops can improve dry eye symptoms and eye comfort. It compares the drops to no treatment to see how well they work.
This trial tests different doses of a new eye drop (HUC1-394) to see which dose works best for people with moderate to severe dry eye disease. You may qualify if your dry eye symptoms have lasted at least 3 months and you have low tear production along with other signs of dry eye.
This study tests two types of preservative-free eye drops to see which is more effective for people with mild to moderate dry eye disease. You will use one of the drops as directed, and the study will monitor your symptoms and eye health over time.
Hear when a new Dry Eye Disease (DED) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.